Johnathan Engh, MDAssociate Professor of Neurological Surgery
Director, Neuroendoport Surgery Program
Director, Adult Neurosurgical Oncology
Johnathan Engh, MD, joined the faculty at the University of Pittsburgh Department of Neurological Surgery in 2008 after completing the department’s seven-year residency program. Originally from northern Virginia, Dr. Engh is a graduate of Duke University and the University of Virginia Medical School.
Dr. Engh’s clinical focus is on neurosurgical oncology, especially minimally invasive operations for central nervous system tumors and intraventricular lesions. He is the director of the adult neurosurgical oncology program as well as the Neuroendoport brain surgery program at the University of Pittsburgh.
From a research perspective, his major interests are the development of minimally invasive tools for cranial surgery and surgical trials for the treatment of brain tumors.
Dr. Engh's publications can be reviewed through the National Library of Medicine's publication database.
See also: Dr. Engh Receives ACES Award
Specialized Areas of Interest
CNS tumors, minimally invasive surgery, neurosurgical technology and innovation.
American Board of Neurological Surgery
Children’s Hospital of Pittsburgh of UPMC
Magee-Womens Hospital of UPMC
Professional Organization Membership
Allegheny County Medical Society
Alpha Omega Alpha
American Association of Neurological Surgeons
Congress of Neurological Surgeons
Pennsylvania Medical Society
Society of Neuro-Oncology
University of Pittsburgh Cancer Institute
Honors and Awards
America’s Best Doctors, 2011-15
Pittsburgh’s Best Doctors, 2012-2015
UPMC ACES Award, 2014
UPMC OnTopic Videos
Neuroendoport® for Brain Tumors
Dr. Engh discusses the benefits of Neuroendoport® surgery to remove brain tumors
19-year-old cyst patient
August 17, 2012
Pitt RB hospitalized: Derrick Burns in stable condition
May 24, 2012
Young Stroke Victims
May 11, 2012
WTAE-TV Action News
Surgery through a straw
February 19, 2009
Dr. Engh’s primary research focus is on the development of better minimally invasive tools for brain surgery. Current projects include modification of a dilatable endoscopic port prototype for brain surgery and development of an animal model of iatrogenic injury related to brain manipulation.
In addition, Dr. Engh is the leader of a brain tumor tissue banking initiative at UPMC which has yielded more than 100 tumoral research specimens. He also is the lead investigator of a trial of fluorescein dye in the resection of brain tumors at UPMC Shadyside, and lead or co-investigator on multiple clinical trials for brain tumor research through the Hillman Cancer Center.